Quest Diagnostics (DGX) Long-Term Investments (2014 - 2026)

Quest Diagnostics has reported Long-Term Investments for 13 years, with the latest figure at $137.0 million in Q2 2026.

• Quarterly Long-Term Investments rose 0.74% year-over-year to $137.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $137.0 million (up 0.74% YoY) and the FY2025 annual result came in at $136.0 million, up 10.57% from the prior year.
• Long-Term Investments rose to $137.0 million in Q2 2026 per DGX's latest filing, from $134.0 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $155.0 million in Q1 2022 and troughed at $123.0 million in Q4 2024.
• A 5-year average of $134.5 million and a median of $134.5 million in 2023 frame the typical range for Long-Term Investments.
• The widest YoY moves for Long-Term Investments: up 32.43% in 2022, down 70.59% in 2022.
• Over 5 years, Long-Term Investments stood at $132.0 million in 2022, then climbed by 2.27% to $135.0 million in 2023, then fell by 8.89% to $123.0 million in 2024, then climbed by 10.57% to $136.0 million in 2025, then increased by 0.74% to $137.0 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $137.0 million, $134.0 million, and $136.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.